Condition: Non-valvular Atrial Fibrillation · Embolic Stroke · Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd.
This clinical study is a prospective, multi-center, non-interventional study designed to investigate the safety and effectiveness of percutaneous LAA appendage closure by using LAmbre™ Left Atrial Appendage Occluder System. 579 patients with valvular AF complicated with previous AF-related embolic events (including ischemic stroke, TIA and systemic embolism) were enrolled at about 20 study sites nationwide. The baseline data, operation process and relevant follow-up information of subjects were recorded at 7 months after operation or before discharge and at 1, 3, 6, 12 and 24 months after operation.
This description comes directly from the study's public registry record.
Chenyang Jiang, Doctor · 8613857190051 · panshangming@lifetechmed.com
Always discuss trial participation with your own doctor first.
| Qilu Hospital of Shandong University | Jinan, Shandong, China | Recruiting |
| Shanghai Songjiang District Central Hospital | Shanghai, Shanghai Municipality, China | Recruiting |
| Sichuan Mianyang 404 Hospital | Mianyang, Sichuan, China | Recruiting |
| The first Affiliated Hospital of WMU | Wenzhou, Zhejiang, China | Recruiting |
| The Second Affiliated Hospital and Yuying Children's Hospital of WMU | Wenzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04559243